| Product Revenue, Net |
3. Product Revenue, Net Product revenue, net, from sales of ARCALYST was as follows: | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | September 30, | | September 30, | | | 2024 | | 2023 | | 2024 | | 2023 | Product revenue, net | | $ | 112,214 | | $ | 64,802 | | $ | 294,493 | | $ | 161,956 |
The following table summarizes balances and activity in each of the product revenue allowance and reserve categories for the nine months ended September 30, 2024: | | | | | | | | | | | | | | | Contractual | | Government | | | | | | | Adjustments | | Rebates | | Returns | | Total | Balance at December 31, 2023 | | $ | 2,022 | | $ | 3,775 | | $ | 341 | | $ | 6,138 | Current provisions relating to sales in the current year | | | 17,228 | | | 13,222 | | | 916 | | | 31,366 | Adjustments relating to prior years | | | (31) | | | (155) | | | 836 | | | 650 | Payments/returns relating to sales in the current year | | | (15,849) | | | (4,538) | | | — | | | (20,387) | Payments/returns relating to sales in the prior years | | | (1,957) | | | (3,620) | | | (192) | | | (5,769) | Balance at September 30, 2024 | | $ | 1,413 | | $ | 8,684 | | $ | 1,901 | | $ | 11,998 |
Total revenue-related reserves as of September 30, 2024 and December 31, 2023, included in our consolidated balance sheets, are summarized as follows: | | | | | | | | | September 30, | | December 31, | | | 2024 | | 2023 | Components of accounts receivable | | $ | (614) | | $ | (459) | Components of other current liabilities | | | 12,612 | | | 6,597 | Total revenue-related reserves | | $ | 11,998 | | $ | 6,138 |
Primarily all of the Company’s trade accounts receivable arise from product revenue in the United States due from the Company’s third party logistics provider.
|